MYC proteins are oncogenes that are implicated in 70% of cancers and are involved in promoting drug resistance in bladder, pancreatic and prostate cancer, but also in haematological malignancies such as multiple myeloma (MM) [21,22,23,24]. Here, MYC is linked to cancer.